Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the
Claudia Fabrizio1, Felice Valzano2, Simone Giuliano3
1Infectious and Tropical Diseases Clinic, San Giuseppe Moscati Hospital, Taranto, Italy.
Abstract:
A 65-year-old man without identifiable risk factors for multidrug-resistant pathogens was admitted with peritonitis, isolating NDM-producing Escherichia coli from a rectal swab and intraoperative samples. After surgery, ceftazidime-avibactam/aztreonam was administered. Due to poor clinical response, he was switched to imipenem-relebactam/aztreonam, resulting in a successful outcome. Whole-genome sequencing detected blaNDM-5 and blaCMY-148 β-lactamases, PBP3 YRIN insertion, and mutated cirA gene. This case illustrates the importance of considering different mechanisms of resistance when choosing combination therapy.
Related Concept Videos
Stringent Response in E. coli
Development of Antibiotic Resistance
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing

